InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Last Andrew J., Chief Operating Officer. Director active across 5 companies, notably OncoCyte Corp. In total, 20 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €908k. History available since 11 June 2021. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations20 total
7,700 shares@ US$5.69100.0% of flowCommon Stock, no par valueSEC:0001493152-26-032233:0
3,000 shares@ US$299.2428.8% of flowBio-Rad A Common StockSEC:0001062993-24-016386:0
3,000 shares@ US$329.938431.8% of flowBio-Rad A Common StockSEC:0001062993-24-016386:1
1,252 shares0Bio-Rad A Common StockSEC:0001062993-24-016169:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-24-009082:0
357 shares@ US$277.113.3% of flowBio-Rad A Common StockSEC:0001062993-24-009082:1
867 shares0Bio-Rad A Common StockSEC:0001062993-23-017654:0
20,000 shares0Common Stock, no par valueSEC:0001493152-23-022669:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-23-009749:0
902 shares0Bio-Rad A Common StockSEC:0001062993-22-019282:0
633 shares0Bio-Rad A Common StockSEC:0001062993-22-019194:0
20,000 shares@ US$0.8733.1% of flowCommon Stock, no par valueSEC:0001493152-22-023524:0
Ideal exit: 14 May 2023 (T+270)
10,000 shares0Common Stock, no par valueSEC:0001493152-22-023385:0
10,000 shares0Common Stock, no par valueSEC:0001493152-22-019822:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-22-011169:0
2,000 shares@ US$299.2450.0% of flowBio-Rad A Common StockSEC:0001062993-21-008244:0
2,000 shares@ US$299.2418.0% of flowBio-Rad A Common StockSEC:0001062993-21-008244
6,993 shares@ US$3.0033.4% of flowCommon StockSEC:0001493152-21-014342
6,993 shares@ US$3.0050.0% of flowCommon StockSEC:0001493152-21-014342:0
37,297 sharesCommon StockSEC:0001140361-16-051546:0
20 of 20 declarations
About Last Andrew J.
Andrew J. Last is a Board Member and the Chief Operating Officer at OncoCyte Corp and BIO-RAD LABORATORIES, INC. He is responsible for managing operations and the company's strategy. Last plays a key role in optimizing processes and implementing new initiatives.
